Development of recombinant inhibitors specific to human kallikrein 2 using phage-display selected substrates

European Journal of Biochemistry

Volumn 271, Issue 3, 2004, Pages 607-613

  Cloutier, Sylvain M ^a,b   Kündig, Christoph ^b   Felber, Loyse M ^a   Fattah, Omar M ^a   Chagas, Jair R ^a   Gygi, Christian M ^c   Jichlinski, Patrice ^a   Leisinger, Hans Jürg ^a   Deperthes, David ^a,b,d  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b Medical Discovery SA   (Switzerland)

^c UNIVERSIDADE DE MOGI DAS CRUZES   (Brazil)

^d Urology Research Unit   (Switzerland)

Author keywords

1 antichymotrypsin; Human kallikrein; Inhibitor; Phage display; Protease

Indexed keywords

ALPHA 1 ANTICHYMOTRYPSIN; KALLIKREIN; KALLIKREIN INHIBITOR; SERINE PROTEINASE;

ARTICLE; CARCINOGENESIS; CONTROLLED STUDY; ENZYME INHIBITION; ENZYME KINETICS; HUMAN; HUMAN CELL; PHAGE DISPLAY; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROTEIN PROTEIN INTERACTION;

BACTERIOPHAGES; BASE SEQUENCE; BLOTTING, WESTERN; DNA PRIMERS; HUMANS; HYDROLYSIS; KINETICS; MUTAGENESIS, SITE-DIRECTED; RECOMBINANT PROTEINS; SERINE PROTEINASE INHIBITORS; TISSUE KALLIKREINS;

EID: 0842309048     PISSN: 00142956     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1432-1033.2003.03963.x     Document Type: Article

References (31)

1. Deperthes, D., Chapdelaine, P., Tremblay, R.R., Brunet, C., Berton, J., Hebert, J., Lazure, C. & Dube, J.Y. (1995) Isolation of prostatic kallikrein hK2, also known as hGK-1, in human seminal plasma. Biochim. Biophys. Acta 1245, 311-316.
2. Tremblay, R.R., Deperthes, D., Tetu, B. & Dube, J.Y. (1997) Immunohistochemical study suggesting a complementary role of kallikreins hK2 and hK3 (prostate-specific antigen) in the functional analysis of human prostate tumors. Am. J. Pathol. 150, 455-459.
3. Darson, M.F., Pacelli, A., Roche, P., Rittenhouse, H.G., Wolfert, R.L., Young, C.Y., Klee, G.G., Tindall, D.J. & Bostwick, D.G. (1997) Human glandular kallikrein 2 (hK2) expression in prostatic intraepithelial neoplasia and adenocarcinoma: a novel prostate cancer marker. Urology 49, 857-862.
4. Darson, M.F., Pacelli, A., Roche, P., Rittenhouse, H.G., Wolfert, R.L., Saeid, M.S., Young, C.Y., Klee, G.G., Tindall, D.J. & Bostwick, D.G. (1999) Human glandular kallikrein 2 expression in prostate adenocarcinoma and lymph node metastases. Urology 53, 939-944.
5. Frenette, G., Tremblay, R.R., Lazure, C. & Dube, J.Y. (1997) Prostatic kallikrein hK2, but not prostate-specific antigen (hK3), activates single-chain urokinase-type plasminogen activator. Int. J. Cancer 71, 897-899.
6. Mikolajczyk, S.D., Millar, L.S., Kumar, A. & Saedi, M.S. (1999) Prostatic human kallikrein 2 inactivates and complexes with plasminogen activator inhibitor-1. Int. J. Cancer 81, 438-442.
7. Takayama, T.K., Fujikawa, K. & Davie, E.W. (1997) Characterization of the precursor of prostate-specific antigen. Activation by trypsin and by human glandular kallikrein. J. Biol. Chem. 272, 21582-21588.
8. Deperthes, D., Frenette, G., Brillard-Bourdet, M., Bourgeois, L., Gauthier, F., Tremblay, R.R. & Dube, J.Y. (1996) Potential involvement of kallikrein hK2 in the hydrolysis of the human seminal vesicle proteins after ejaculation. J. Androl. 17, 659-665.
9. Rehault, S., Monget, P., Mazerbourg, S., Tremblay, R., Gutman, N., Gauthier, F. & Moreau, T. (2001) Insulin-like growth factor binding proteins (IGFBPs) as potential physiological substrates for human kallikreins hK2 and hK3. Eur J. Biochem. 268, 2960-2968.
10. Huntington, J.A., Read, R.J. & Carrell, R.W. (2000) Structure of a serpin-protease complex shows inhibition by deformation. Nature 407, 923-926.
11. Dufour, E.K., Denault, J.B., Bissonnette, L., Hopkins, P.C., Lavigne, P. & Leduc, R. (2001) The contribution of arginine residues within the P6-P1 region of alpha 1-antitrypsin to its reaction with furin. J. Biol. Chem. 276, 38971-38979.
12. Luke, C., Schick, C., Tsu, C., Whisstock, J.C., Irving, J.A., Bromme, D., Juliano, L., Shi, G.P., Chapman, H.A. & Silverman, G.A. (2000) Simple modifications of the serpin reactive site loop convert SCCA2 into a cysteine proteinase inhibitor: a critical role for the P3′ proline in facilitating RSL cleavage. Biochemistry 39, 7081-7091.
13. Plotnick, M.I., Rubin, H. & Schechter, N.M. (2002) The effects of reactive site location on the inhibitory properties of the serpin alpha (1)-antichymotrypsin. J. Biol. Chem. 277, 29927-29935.
14. Frenette, G., Deperthes, D., Tremblay, R.R., Lazure, C. & Dube, J.Y. (1997) Purification of enzymatically active kallikrein hK2 from human seminal plasma. Biochim. Biophys. Acta 1334, 109-115.
15. Saedi, M.S., Zhu, Z., Marker, K., Liu, R.S., Carpenter, P.M., Rittenhouse, H. & Mikolajczyk, S.D. (2001) Human kallikrein 2 (hK2), but not prostate-specific antigen (PSA), rapidly complexes with protease inhibitor 6 (PI-6) released from prostate carcinoma cells. Int. J. Cancer 94, 558-563.
16. Cloutier, S.M., Chagas, J.R., Mach, J.P., Gygi, C.M., Leisinger, H.J. & Deperthes, D. (2002) Substrate specificity of human kallikrein 2 (hK2) as determined by phage display technology. Eur. J. Biochem. 269, 2747-2754.
17. Frenette, G., Gervais, Y., Tremblay, R.R. & Dube, J.Y. (1998) Contamination of purified prostate-specific antigen preparations by kallikrein hK2. J. Urol. 159, 1375-1378.
18. Mahajan, N.P., Harrison-Shostak, D.C., Michaux, J. & Herman, B. (1999) Novel mutant green fluorescent protein protease substrates reveal the activation of specific caspases during apoptosis. Chem. Biol. 6, 401-409.
19. Laemmli, U.K. (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227, 680-685.
20. Morrison, J.F. & Walsh, C.T. (1988) The behavior and significance of slow-binding enzyme inhibitors. Adv. Enzymol. Relat. Areas Mol. Biol. 61, 201-301.
21. Lawrence, D.A., Ginsburg, D., Day, D.E., Berkenpas, M.B., Verhamme, I.M., Kvassman, J.O. & Shore, J.D. (1995) Serpin-protease complexes are trapped as stable acyl-enzyme intermediates. J. Biol. Chem. 270, 25309-25312.
22. Cooley, J., Takayama, T.K., Shapiro, S.D., Schechter, N.M. & Remold-O'Donnell, E. (2001) The serpin MNEI inhibits elastase-like and chymotrypsin-like serine proteases through efficient reactions at two active sites. Biochemistry 40, 15762-15770.
23. Schechter, N.M., Sprows, J.L., Schoenberger, O.L., Lazarus, G.S., Cooperman, B.S. & Rubin, H. (1989) Reaction of human skin chymotrypsin-like proteinase chymase with plasma proteinase inhibitors. J. Biol. Chem. 264, 21308-21315.
24. Duranton, J., Adam, C. & Bieth, J.G. (1998) Kinetic mechanism of the inhibition of cathepsin G by alpha 1-antichymotrypsin and alpha 1-proteinase inhibitor. Biochemistry 37, 11239-11245.
25. Christensson, A., Laurell, C.B. & Lilja, H. (1990) Enzymatic activity of prostate-specific antigen and its reactions with extracellular serine proteinase inhibitors. Eur. J. Biochem. 194, 755-763.
26. Rubin, H., Wang, Z.M., Nickbarg, E.B., McLarney, S., Naidoo, N., Schoenberger, O.L., Johnson, J.L. & Cooperman, B.S. (1990) Cloning, expression, purification, and biological activity of recombinant native and variant human alpha 1-antichymotrypsins. J. Biol. Chem. 265, 1199-1207.
27. Pimenta, D.C., Chen, V.C., Chao, J., Juliano, M.A. & Juliano, L. (2000) Alpha1-antichymotrypsin and kallistatin hydrolysis by human cathepsin D. J. Protein Chem. 19, 411-418.
28. Plotnick, M.I., Schechter, N.M., Wang, Z.M., Liu, X. & Rubin, H. (1997) Role of the P6-P3′ region of the serpin reactive loop in the formation and breakdown of the inhibitory complex. Biochemistry 36, 14601-14608.
29. Deperthes, D., Marceau, F., Frenette, G., Lazure, C., Tremblay, R.R. & Dube, J.Y. (1997) Human kallikrein hK2 has low kininogenase activity while prostate-specific antigen (hK3) has none. Biochim. Biophys. Acta 1343, 102-106.
30. Almeida, P.C., Chagas, J.R., Cezari, M.H., Juliano, M.A. & Juliano, L. (2000) Hydrolysis by plasma kallikrein of fluorogenic peptides derived from prorenin processing site. Biochim. Biophys. Acta 1479, 83-90.
31. Bourgeois, L., Brillard-Bourdet, M., Deperthes, D., Juliano, M.A., Juliano, L., Tremblay, R.R., Dube, J.Y. & Gauthier, F. (1997) Serpin-derived peptide substrates for investigating the substrate specificity of human tissue kallikreins hK1 and hK2. J. Biol. Chem. 272, 29590-29595.